DBVTF (DBV Technologies) Tariff Resilience Score: 6/10 (As of Jul. 02, 2026)


DBVTF DBV Technologies SA DBVTF
27 GF Score
Price $4.26
! 1 Warning Sign
View Full Analysis

What is DBV Technologies Tariff Resilience Score?

DBV Technologies DBVTF 27 Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus rates DBVTF with a GF Score™ of 27/100. The stock has 1 warning sign investors should review. Among 1,374 Biotechnology companies, DBV Technologies ranks better than 75.98% on this metric.

DBV Technologies has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

DBV Technologies has DBV Technologies, a biotech firm, faces moderate tariff exposure due to its reliance on international suppliers for research materials. However, its niche market and potential for pricing power mitigate some risks. Past tariffs have had limited impact.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes DBV Technologies might have Average Resilient.

DBV Technologies  (OTCPK:DBVTF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

DBV Technologies Tariff Resilience Score Related Terms

DBVTF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, DBV Technologies's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DBV Technologies Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DBV Technologies's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where DBV Technologies's Tariff Resilience Score falls into.


DBVTF
27GF Score
DBV Technologies SA DBVTF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
DBV Technologies (DBVTF) has a Tariff Resilience Score of 6 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, DBV Technologies ranks #330 out of 1374 companies in the Biotechnology industry, placing it in the top 24%.
Is DBV Technologies' Tariff Resilience Score too high?
DBV Technologies' current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. DBV Technologies' value of 6 is 50% above this industry median. Based on the distribution chart, DBV Technologies ranks #330 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, DBV Technologies has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does DBV Technologies' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, DBV Technologies ranks #330 out of 1374 companies for Tariff Resilience Score. This places DBV Technologies in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. DBV Technologies' value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DBV Technologies's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DBV Technologies's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DBV Technologies stock overvalued right now?
DBV Technologies (DBVTF) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. DBV Technologies' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For DBV Technologies (DBVTF), the current Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DBV Technologies Business Description

Address 107 Avenue de la Republique, Batiment IRO, Chatillon, Paris, FRA, 92320
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
27GF Score

Get the complete analysis for DBVTF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.26
Price